Aroa Biosurgery Investor Relations Material
Latest events
AGM 2025
Aroa Biosurgery
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aroa Biosurgery Limited
Access all reports
Aroa Biosurgery Limited develops and manufactures regenerative tissue repair products derived from extracellular matrix biomaterials. The company’s products are used in wound care, soft tissue reconstruction, and surgical applications. Aroa Biosurgery serves healthcare providers and medical institutions across international markets. The company is headquartered in Auckland, New Zealand, and its shares are listed on the ASX.
Key slides for Aroa Biosurgery Limited
AGM 2025
Aroa Biosurgery Limited
H2 2025
Aroa Biosurgery Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ARX
Country
🇦🇺 Australia